Loading
IP
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) Stock: price and insider trades · Canada
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,): what insiders have been doing
This page follows insider dealings at InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) as filed with SEDI. InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) has had no insider filing for more than a year; the last one goes back to 22 August 2017.
Over the whole record (from 2016), the tally stands at 29 purchases and 18 sales.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
66
Thresholds
n/a
Buy Volume
€260,604
29 ops. · all time
Sell Volume
€267,196
18 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 22 August 2017
Declarations66 total
10,000 shares@ CA$0.304.3% of flowCommon SharesTSXSEDI:3049741
10,500 shares@ CA$0.2954.5% of flowCommon SharesTSXSEDI:3049743
129,500 shares@ CA$0.2954.4% of flowCommon SharesTSXSEDI:3049744
357,143 sharesCommon SharesTSXSEDI:3040359
20,000 shares@ CA$0.321.5% of flowCommon SharesTSXSEDI:3034771
Canonical exit: 9 Oct 2017 (T+90)
100,000 shares@ CA$0.45100.0% of flowCommon SharesTSXSEDI:3014289
Canonical exit: 29 Aug 2017 (T+90)
Common SharesTSXSEDI:3014285
500,000 shares@ CA$0.14100.0% of flowCommon SharesTSXSEDI:3005098
20,000 shares@ CA$0.150.4% of flowCommon SharesTSXSEDI:2952403
Canonical exit: 2 Mar 2017 (T+90)
147,000 shares@ CA$0.16093.5% of flowCommon SharesTSXSEDI:2952400
100,000 shares@ CA$0.18100.0% of flowCommon SharesTSXSEDI:2947397
Common SharesTSXSEDI:2947394
Common SharesTSXSEDI:2909272
20,000 shares@ CA$0.1450.7% of flowCommon SharesTSXSEDI:2909247
Canonical exit: 1 Feb 2017 (T+90)
25,000 shares@ CA$0.161.0% of flowCommon SharesTSXSEDI:2909246
Canonical exit: 31 Jan 2017 (T+90)
Common SharesTSXSEDI:2907171
625,000 shares@ CA$0.08100.0% of flowCommon SharesTSXSEDI:2907174
2,125,000 shares@ CA$0.0824.7% of flowCommon SharesTSXSEDI:2907283
2,975,000 shares@ CA$0.0860.1% of flowCommon SharesTSXSEDI:2906901
Canonical exit: 25 Jan 2017 (T+90)
5,000 shares@ CA$0.1850.2% of flowCommon SharesTSXSEDI:2906902
Canonical exit: 29 Jan 2017 (T+90)
50,000 shares@ CA$0.182.3% of flowCommon SharesTSXSEDI:2906903
Canonical exit: 29 Jan 2017 (T+90)
1,000,000 shares@ CA$0.1724.7% of flowCommon SharesTSXSEDI:2906218
100,000 shares@ CA$0.182.6% of flowCommon SharesTSXSEDI:2906214
1,250,000 shares@ CA$0.0814.7% of flowCommon SharesTSXSEDI:2904487
25,000 shares@ CA$0.110.7% of flowCommon SharesTSXSEDI:2899777
25 of 66 declarations
About InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,)
InMed Pharmaceuticals Inc., formerly Cannabis Technologies Inc., is a biopharmaceutical company focused on developing cannabinoid-based therapies for serious diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.
